Drugs / LF-PB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01754285 | Nov 2012 → May 2014 | — | Chemi S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LF-PB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01754285 ↗ |
| Route | Intramuscular | “Mode of administration is single intramuscular (IM) injection” NCT01754285 ↗ |